Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28288256.
- Also identified by DOI 10.1001/jamainternmed.2017.0033 and PMC identifier 5470354.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review of FDA’s Drug Trials Snapshots Program evaluates the sex-specific findings reported as part of the approval process for all cardiovascular drugs that the FDA approved in 2015.
Medical subject headings
- Cardiovascular Agents
- Cardiovascular Diseases
- Clinical Trials as Topic
- Patient Selection
- Women's Health